Results 101 to 110 of about 31,199 (226)
Intravitreal injections: A brief note
Kerala Journal of Ophthalmology, 2018 The delivery of medications directly into the vitreous cavity through an injection or implant has become a commonplace in ophthalmology. Common diseases treated by intravitreal injections include neovascular age-related macular degeneration, clinically ...
Anu Joseph
doaj +1 more source
Neovascular Age-related Macular Degeneration
, 2022 This thesis describes the treatment of exudative Age-Related Macular Degeneration (ARMD) with bevacizumab. The main object of the thesis was to evaluate the viability of less frequent bevacizumab dosage regiments. Furthermore, the reactivation interval of CNV was observed, and we delved deeper into a specific kind of CNV and its characteristics using a
openaire +1 more source
Clinical Ophthalmology, 2022 Jeffrey K Luttrull,1 Gerry Gray2 1Ventura County Retina Vitreous Medical Group, Ventura, CA, USA; 2Regulatory Pathways, Inc, Laguna Beach, CA, USACorrespondence: Jeffrey K Luttrull, Ventura County Retina Vitreous Medical Group, 3160 Telegraph Road, Suite
Luttrull JK, Gray G
doaj
Current perspectives on ranibizumab
Clinical Ophthalmology, 2015 Vaidehi S Dedania,1 Sophie J Bakri21Department of Ophthalmology, Albany Medical Center, Lions Eye Institute, Albany, NY, USA; 2Department of Ophthalmology, Mayo Clinic, Rochester, MN, USABackground: This review summarizes the Phase III studies addressing
Dedania VS, Bakri SJ
doaj
Treatment of neovascular age-related macular degeneration: Current therapies
Clinical Ophthalmology, 2009 Albert J Augustin, Stefan Scholl, Janna KirchhofDepartment of Ophthalmology, Klinikum Karlsruhe, GermanyAbstract: Choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD) is now the leading cause of blindness and severe ...
Albert J Augustin +2 more
doaj
Long-Term Follow-Up of Dry Age-Related Macular Degeneration Patients
Journal of Current OphthalmologyPurpose: To assess the progression rate from dry age-related macular degeneration (dAMD) to advanced AMD and possible risk factors. Methods: Demographics, medical and ocular conditions, baseline eye examinations, optical coherence tomography features ...
Elham Sadeghi +8 more
doaj +1 more source
Gene Transfer for Neovascular Age-Related Macular Degeneration [PDF]
Human Gene Therapy, 2011 Age-related macular degeneration (AMD) is a complex disease that has two phases: a degenerative phase often referred to as nonneovascular AMD (non-NVAMD) or dry AMD and a phase dominated by growth of new blood vessels in the subretinal space, referred to as NVAMD or wet AMD.
openaire +2 more sources
Treatment of neovascular age-related macular degeneration in patients with diabetes
Clinical Ophthalmology, 2008 Michael Cummings1, José Cunha-Vaz21Academic Department of Diabetes and Endocrinology, Queen Alexandra Hospital, Portsmouth, UK; 2Department of Ophthalmology, University Hospital of Coimbra, Centre of Ophthalmology, Institute of Biomedical ...
Michael Cummings +1 more
doaj
Clinical Ophthalmology, 2013 Yousif Subhi, Amardeep Singh, Mads Krüger Falk, Torben Lykke SørensenDepartment of Ophthalmology, Clinical Eye Research Unit, Copenhagen University Hospital Roskilde and the University of Copenhagen, Copenhagen, DenmarkPurpose: Association of
Subhi Y +3 more
doaj
Journal of OphthalmologyConclusions: In “treatment-resistant” patients receiving anti-VEGF therapy for neovascular age-related macular degeneration or diabetic macular edema, switching to IFI in a “real-world” TAE protocol led to statistically significant improvements in ...
Shravan V. Savant +7 more
doaj +1 more source